Showing results (131-140 of 151) with videos related to
Sort By:
Pageof 16
Annals of Hematology|October 4, 2023
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trialSteffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.Plos One|December 19, 2013
Stress responses of the industrial workhorse Bacillus licheniformis to osmotic challengesRebecca Schroeter, Tamara Hoffmann, Birgit Voigt, et al.European Journal of Haematology|July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical RoutineSteffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 5, 2013
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple MyelomaBritta Auel, Hartmut Goldschmidt, Thomas Geer, et al.Proteomics|February 27, 2010
Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulationAnne-Kathrin Ziebandt, Harald Kusch, Marco Degner, et al.Zeitschrift Fur Orthopadie Und Unfallchirurgie|September 16, 2017
[Biologic Reconstruction of Full Sized Cartilage Defects of the Hip: A Guideline from the DGOU Group "Clinical Tissue Regeneration" and the Hip Committee of the AGA]Stefan Fickert, Matthias Aurich, Dirk Albrecht, et al.Proceedings of the National Academy of Sciences of the United States of America|April 21, 2012
Metaproteomics of a gutless marine worm and its symbiotic microbial community reveal unusual pathways for carbon and energy useManuel Kleiner, Cecilia Wentrup, Christian Lott, et al.Journal of Cancer Research and Clinical Oncology|February 16, 2017
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin careCarl Christoph Schimanski, Frank Staib, Thomas Göhler, et al.Nature Communications|November 3, 2024
Distribution and diversity of classical deacylases in bacteriaLeonie G Graf, Carlos Moreno-Yruela, Chuan Qin, et al.British Journal of Cancer|October 14, 2025
Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)Manfred P Lutz, Nikolaus Ansorge, Gleb Barmashenko, et al.Pageof 16